J 2024

Investigation of long non-coding RNAs in extracellular vesicles from low-volume blood serum specimens of colorectal cancer patients

BOUDNÁ, Marie; Táňa MACHÁČKOVÁ; Petra VYCHYTILOVÁ; Karolína TRACHTOVÁ; Renata BARTOŠOVÁ et. al.

Basic information

Original name

Investigation of long non-coding RNAs in extracellular vesicles from low-volume blood serum specimens of colorectal cancer patients

Authors

BOUDNÁ, Marie; Táňa MACHÁČKOVÁ; Petra VYCHYTILOVÁ; Karolína TRACHTOVÁ; Renata BARTOŠOVÁ; Tina CATELA IVKOVIĆ; Dagmar AL TUKMACHI; Robin JUGAS; Lucie PIFKOVÁ; Jana ORLÍČKOVÁ; Jan KOTOUČEK; Markéta PAVLÍKOVÁ; Milana ŠACHLOVÁ; Lucia BOHOVICOVÁ; Teodor STANĚK; Jana HALÁMKOVÁ; Igor KISS; Tomáš GROLICH; Martin SVOBODA; Zdeněk KALA; Kamila SOUČKOVÁ and Ondřej SLABÝ

Edition

CLINICAL AND EXPERIMENTAL MEDICINE, ITALY, SPRINGER-VERLAG ITALIA SRL, 2024, 1591-8890

Other information

Language

English

Type of outcome

Article in a journal

Country of publisher

Italy

Confidentiality degree

is not subject to a state or trade secret

References:

Organization

Lékařská fakulta – Repository – Repository

UT WoS

001197026300001

EID Scopus

2-s2.0-85189205062

Keywords in English

Biomarker; Colorectal cancer; EVs; lncRNAs.

Links

GA20-18889S, research and development project. LX22NPO5102, research and development project. BBMRI-CZ III, large research infrastructures. NCMG II, large research infrastructures.
Changed: 4/4/2025 00:50, RNDr. Daniel Jakubík

Abstract

V originále

Colorectal cancer (CRC) is the second most prevalent cancer type worldwide, which highlights the urgent need for non-invasive biomarkers for its early detection and improved prognosis. We aimed to investigate the patterns of long non-coding RNAs (lncRNAs) in small extracellular vesicles (sEVs) collected from low-volume blood serum specimens of CRC patients, focusing on their potential as diagnostic biomarkers. Our research comprised two phases: an initial exploratory phase involving RNA sequencing of sEVs from 76 CRC patients and 29 healthy controls, and a subsequent validation phase with a larger cohort of 159 CRC patients and 138 healthy controls. Techniques such as dynamic light scattering, transmission electron microscopy, and Western blotting were utilized for sEV characterization. Optimized protocol for sEV purification, RNA isolation and preamplification was applied to successfully sequence the RNA content of sEVs and validate the results by RT-qPCR. We successfully isolated sEVs from blood serum and prepared sequencing libraries from a low amount of RNA. High-throughput sequencing identified differential levels of 460 transcripts between CRC patients and healthy controls, including mRNAs, lncRNAs, and pseudogenes, with approximately 20% being lncRNAs, highlighting several tumor-specific lncRNAs that have not been associated with CRC development and progression. The validation phase confirmed the upregulation of three lncRNAs (NALT1, AL096828, and LINC01637) in blood serum of CRC patients. This study not only identified lncRNA profiles in a population of sEVs from low-volume blood serum specimens of CRC patients but also highlights the value of innovative techniques in biomolecular research, particularly for the detection and analysis of low-abundance biomolecules in clinical samples. The identification of specific lncRNAs associated with CRC provides a foundation for future research into their functional roles in cancer development and potential clinical applications.

Files attached